Skip to main content
. Author manuscript; available in PMC: 2010 Aug 13.
Published in final edited form as: J Med Chem. 2009 Aug 13;52(15):4716–4724. doi: 10.1021/jm900159g

Figure 4.

Figure 4

1 treatment caused dose-dependent dephosphorylation of VEGFR-3 and decreased phosphorylation of FAK. A and B, Western blot analysis of MCF7-VEGFR-3 breast cancer cells and BT474 breast cancer cells after 24 h of treatment with increasing doses of 1. VEGFR-3 phosphorylation was analyzed. C and D, Immunoprecipitation of FAK and Western blot analysis with anti-phosphotyrosine antibody 4G10 of MCF7-VEGFR-3 and BT474 cells treated for 24 h with 10 µM or 1 µM of 1.